HCM
MDXH icon

Heights Capital Management’s MDxHealth MDXH Stock Holding History

Heights Capital Management’s Portfolio MDXH Stock Details MDXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-325,000
Closed -$676K – 155
2024
Q3 		$676K Buy
+325,000
New +$882K 0.5% 28

Other funds holding MDXH

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Heights Capital Management's MDXH Position: Q4 2024 in Review

Heights Capital Management sold out of MDxHealth (MDXH) in Q4 2024, closing a stake of 325,000 shares — an estimated $676K sold.

Heights Capital Management first reported a position in MDXH in Q3 2024 and held it in 1 quarter. The position peaked at $676K in Q3 2024. 24 funds tracked by Wall St. Rank hold MDXH as of Q4 2024.

  • Heights Capital Management reported no remaining MDxHealth position as of Q4 2024 after selling out during the quarter.
  • Heights Capital Management sold 325,000 MDxHealth shares in Q4 2024, an estimated $676K.
  • Heights Capital Management first reported a position in MDxHealth in Q3 2024 and held it in 1 quarter.
  • Heights Capital Management's MDxHealth position peaked at $676K in Q3 2024.
  • 24 funds tracked by Wall St. Rank held MDxHealth as of Q4 2024.

Based on Heights Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.